Arthur F. Ryan - 01 Feb 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Issuer symbol
REGN
Transactions as of
01 Feb 2024
Net transactions value
-$95,422
Form type
4
Filing time
05 Feb 2024, 16:05:50 UTC
Previous filing
04 Jan 2024
Next filing
05 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $940 -1 -0.01% $939.53 18,481 01 Feb 2024 Direct F1
transaction REGN Common Stock Sale $5,651 -6 -0.03% $941.91 18,475 01 Feb 2024 Direct F1, F2
transaction REGN Common Stock Sale $4,712 -5 -0.03% $942.50 18,470 01 Feb 2024 Direct F1, F3
transaction REGN Common Stock Sale $2,831 -3 -0.02% $943.54 18,467 01 Feb 2024 Direct F1, F4
transaction REGN Common Stock Sale $945 -1 -0.01% $944.66 18,466 01 Feb 2024 Direct F1
transaction REGN Common Stock Sale $2,842 -3 -0.02% $947.37 18,463 01 Feb 2024 Direct F1, F5
transaction REGN Common Stock Sale $949 -1 -0.01% $948.77 18,462 01 Feb 2024 Direct F1
transaction REGN Common Stock Sale $9,495 -10 -0.05% $949.48 18,452 01 Feb 2024 Direct F1, F6
transaction REGN Common Stock Sale $1,900 -2 -0.01% $950.01 18,450 01 Feb 2024 Direct F1, F7
transaction REGN Common Stock Sale $2,854 -3 -0.02% $951.40 18,447 01 Feb 2024 Direct F1, F8
transaction REGN Common Stock Sale $2,860 -3 -0.02% $953.18 18,444 01 Feb 2024 Direct F1, F9
transaction REGN Common Stock Sale $4,773 -5 -0.03% $954.52 18,439 01 Feb 2024 Direct F1, F10
transaction REGN Common Stock Sale $9,554 -10 -0.05% $955.35 18,429 01 Feb 2024 Direct F1, F11
transaction REGN Common Stock Sale $6,693 -7 -0.04% $956.21 18,422 01 Feb 2024 Direct F1, F12
transaction REGN Common Stock Sale $2,873 -3 -0.02% $957.75 18,419 01 Feb 2024 Direct F1, F13
transaction REGN Common Stock Sale $4,793 -5 -0.03% $958.65 18,414 01 Feb 2024 Direct F1, F14
transaction REGN Common Stock Sale $7,677 -8 -0.04% $959.68 18,406 01 Feb 2024 Direct F1, F15
transaction REGN Common Stock Sale $9,605 -10 -0.05% $960.52 18,396 01 Feb 2024 Direct F1, F16
transaction REGN Common Stock Sale $3,845 -4 -0.02% $961.37 18,392 01 Feb 2024 Direct F1, F17
transaction REGN Common Stock Sale $5,775 -6 -0.03% $962.49 18,386 01 Feb 2024 Direct F1, F18
transaction REGN Common Stock Sale $3,855 -4 -0.02% $963.73 18,382 01 Feb 2024 Direct F1, F19
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.
F2 Represents volume-weighted average price of sales of 6 shares of Company stock on February 1, 2024 at prices ranging from $941.83 to $941.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F3 Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2024 at prices ranging from $942.03 to $942.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F4 Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $943.49 to $943.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F5 Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $947.16 to $947.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F6 Represents volume-weighted average price of sales of 10 shares of Company stock on February 1, 2024 at prices ranging from $949.13 to $949.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F7 Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2024 at prices ranging from $950.00 to $950.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F8 Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $951.10 to $951.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F9 Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $953.12 to $953.26. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F10 Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2024 at prices ranging from $954.15 to $954.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F11 Represents volume-weighted average price of sales of 10 shares of Company stock on February 1, 2024 at prices ranging from $955.11 to $955.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F12 Represents volume-weighted average price of sales of 7 shares of Company stock on February 1, 2024 at prices ranging from $956.00 to $956.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F13 Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $957.32 to $957.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F14 Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2024 at prices ranging from $958.48 to $958.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F15 Represents volume-weighted average price of sales of 8 shares of Company stock on February 1, 2024 at prices ranging from $959.14 to $959.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F16 Represents volume-weighted average price of sales of 10 shares of Company stock on February 1, 2024 at prices ranging from $960.18 to $960.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F17 Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2024 at prices ranging from $961.00 to $961.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F18 Represents volume-weighted average price of sales of 6 shares of Company stock on February 1, 2024 at prices ranging from $962.20 to $962.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
F19 Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2024 at prices ranging from $963.54 to $963.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.